Academic Pharmacy Now: 2015 Issue 5

Academic Pharmacy NOW

The News Magazine of the American Association of Colleges of Pharmacy

Volume 8 2015 Issue 5

Future Pharmacy, Vintage Care Also in this issue: A biochemical “trick” creates new opportunities to treat cancer, infertility 8 Type 2 diabetes patients fine-tune their care thanks to UCSD-run clinic 12

A “pharmacy of the future” will use digital tools to redefine the relationship between the pharmacist and the tech-savvy patient 14

who we are @AACPharmacy

Academic Pharmacy The News Magazine of the American Association of Colleges of Pharmacy

American Association of Colleges of Pharmacy 1727 King Street, Floor 2 Alexandria, VA 22314 p: 703-739-2330 P f: 703-836-8982

www.aacp.org

Founded in 1900, the American Association of Colleges of Pharmacy is the national organization representing the interests of pharmacy education. AACP comprises all accredited colleges and schools of pharmacy, including more than 6,600 faculty, approximately 63,800 students enrolled in professional programs and 4,800 individuals pursuing graduate study.

Letters to the Editor

NOW

CEO & Publisher

Lucinda L. Maine

Editorial Director

Lynette R. Bradley-Baker

Editor

Maureen Thielemans

mthielemans@aacp.org

Editorial Assistant

Kyle R. Bagin

kbagin@aacp.org

We welcome your comments.

Please submit all letters to the editor to communications@aacp.org.

About Academic Pharmacy Now Academic Pharmacy Now highlights the work of AACP member pharmacy schools and faculty. The magazine is published as a membership service.

Subscriptions To subscribe, visit http://www.aacp.org/news/ shopaacp/Pages/publications.aspx.

Change of Address For address changes, contact Terry J. Ryan, Associate Director of Membership Development, at tryan@aacp.org.

Advertising For advertising rates, please visit http://www.aacp.org/news/academic pharmnow/pages/advertisingwithaacp.aspx. Š2015 by the American Association of Colleges of Pharmacy. All rights reserved. Content may not be reprinted without prior written permission.

2

Academic Pharmacy NOW  2015 Issue 5

Art Director

Tricia Gordon

tgordon@aacp.org

Web Designer

Sean Clark

sclark@aacp.org

Freelance Writer

Jane E. Rooney

Freelance Writer

Athena Ponushis

Senior Advisor, Outreach and Communications

Stephanie Saunders Fouch sfouch@aacp.org

Volume 8 2015 Issue 5

@AACPharmacy a look inside

campus connection

4 Medication Management

Goes Under the Microscope A sizable grant will enable UNC’s Eshelman School of Pharmacy to study comprehensive medication management in primary care medical practices.

6

The Power of Plants

8

A Longer Lifespan for Peptides

UIC will use $10M in federal grants to study botanicals for human health.

A new approach developed at University of the Pacific could pave the way for more effective peptide therapies.

community impact

10 12

A First for Fat Researchers at Washington State University show how fatty acids can fight prostate cancer.

14

Moving Pharmacy Forward,

By Looking Back ‘Pharmacy of the future’ redefines the relationship between the patient and pharmacist.

Redefining Diabetes Care— and the Pharmacist’s Role A team from the University of California, San Diego gives patients with type 2 diabetes a healthcare “tune-up.”

@AACPharmacy

18

AJPE Call for Papers on Interprofessional Education The American Journal of Pharmaceutical Education (AJPE), in conjunction with The Journal of the American Osteopathic Association (JAOA), is seeking original research, reviews, and commentary for a special joint theme issue on interprofessional education.

19 19

2016 AACP Interim Meeting February 20–23 Tampa Marriott Waterside Hotel & Marina Tampa, Florida

Maximize Your AACP Membership in 2016

Academic Pharmacy NOW  2015 Issue 5

3

publisher’s note

Dear Colleagues: Innovation, Inspiration, Information and Invitation. As I begin to turn out the lights on 2015 these are the words that come to mind. The issue of Academic Pharmacy Now is full of them.

The plan-of-action of the ACCP-funded project to study comprehensive medication management in primary care practices is extremely exciting. The collaboration between the three primary organizations, including two pharmacy schools and a physician association research network, exemplifies how much more innovation we can realize if we don’t always think we have to invent “stuff” all by ourselves. Diverse perspectives on a problem and its resolution is simply more powerful than figuring it out single-handedly.

AACP has learned a great deal about the power of information sharing this year in the work of Dana Thimons, our Sewell Memorial Fund Fellow. As a library scientist and information specialist, Dana has been embedded in our organization for 12 months to study the field and practices of knowledge management (KM). We knew we had a lot of information, both as an association and as part of the Academy. All of our member groups create important information aimed at resolving challenges in the Academy, but too often the inability of one group to find the work of another results in reinventing wheels. AACP stands ready to implement a KM culture and the Academy will benefit from this commitment.

Knowledge management is one of three priorities that have guided the Association strategically throughout the last 12 to 18 months. Enhancing our communications effort and implementing educational innovation with serious games for interprofessional learning are the other two. There has never been a more important time to commit to expanding communications to prospective students, their parents, their guidance counselors and others about the impact pharmacists and pharmaceutical scientists have on health and society.

As 2016 dawns, AACP is embarking on a revision of our strategic plan. Surveys have gone to our leaders and to those who currently serve as delegates to the AACP House. I invite all of our readers to submit your thoughts, dreams, aspirations and needs to integrate into our planning process. Simply send an email to mail@aacp.org and use Planning Input in the subject line.

I wish you and yours a safe, happy and restful holiday season.

The AACP staff looks forward to great things happening in 2016!

Sincerely,

Lucinda L. Maine, Ph.D., R.Ph. CEO and Publisher

campus connection

Medication Management Goes Under the Microscope

A sizable grant will enable UNC’s Eshelman School of Pharmacy to study comprehensive medication management in primary care medical practices.

By Jane E. Rooney Strategies that address safe and effective medication use in primary care are key to enhancing patients’ health and controlling costs. Comprehensive medication management (CMM) is gaining support as a way to optimize medication use. The University of North Carolina at Chapel Hill’s

4

Academic Pharmacy NOW  2015 Issue 5

Eshelman School of Pharmacy will study the impact of implementing CMM in primary care medical practices under a $2.4 million grant it received from the American College of Clinical Pharmacy and the ACCP Research Institute. UNC’s collaborators on the project will be the Alliance for Inte-

campus connection

grated Medication Management (AIMM), the University of Minnesota College of Pharmacy, and the American Academy of Family Physicians National Research Network.

policymakers and payers to include this as part of the new healthcare delivery and payment system? These are important questions.”

The study will build on previous work to evaluate the impact of CMM but will also look at how to implement it based on findings from the 45 clinics participating in the project. According to the American College of Clinical Pharmacy President Dr. Judith Jacobi, no study of consistent CMM practice across such a diverse mix of real-world practice settings has ever been carried out.

Replicating Best Practices

The first phase of the study is to assess the clinics’ current CMM programs and determine how to build on their success.

Sorensen said the research will tackle several questions: “Are the priorities that have driven integration of these services in these clinics the same everywhere or do they vary? Understanding the influence of organizational priorities is an important part of understanding how to replicate this.” In “We’re studying the innovators to understand how they did working with a diverse group of clinics—some urban, some it so we can help replicate this practice across the country,” suburban, some serving Medicaid patients, for example—resaid Dr. Todd Sorensen, professor and associate department searchers will observe clinics in the midst of operation to head, University of Minnesota College of Pharmacy and exdetermine best practices that they can share with others. ecutive director for AIMM. “We’re studying how to accelerate Just as important will be understanding how the clinics’ can the adoption of this service, which has not really been done.” expand the reach of their programs.

Dr. Mary Roth McClurg, associate professor, UNC’s Eshelman School of Pharmacy, and principal investigator on the grant, added that they want to explore how CMM works and how to operationalize it. “When we show people how to do it, how do we then communicate and disseminate that in a way that allows them to implement it? How do we convince

McClurg noted that as the team learns about the metrics that work, they want to share findings in a timely manner. “We hope to be able to demonstrate the impact pharmacists are having on these practice-level metrics. We must be able to identify best practices and disseminate the information in real time for others to replicate,” she said, emphasizing that this will not be a controlled trial because it would be unrealistic in healthcare’s rapidly evolving world.

Some of the questions the study will address include:

M M C

•

Which patients and populations within primary care practices benefit the most from CMM? Are those in greatest need receiving CMM, and if so, what are best practices around the patient encounter, including frequency of follow-up?

•

Among those who receive CMM, what is the effect on quality of care and the patient experience?

•

Which quality performance metrics are most relevant to today’s primary care medical practices, and what are the contributions of the clinical pharmacist to helping the practice achieve those metrics?

•

How should CMM be delivered, replicated, scaled and sustained?

•

What is the return on investment to the primary care medical practice from having a clinical pharmacist in the clinic?

•

As healthcare shifts from fee-for-service to value-based care delivery, how does the healthcare team best optimize medication use to ensure high quality care?

Academic Pharmacy NOW  2015 Issue 5

5

campus connection

Shared Learning Partnering with other organizations—including another pharmacy school and an organization of medical providers—bolstered UNC’s grant proposal, according to McClurg.

“We realized we have many strengths but we also knew there were areas where we needed to diversify our talents,” she explained. “Having Minnesota and its five integrated health systems just strengthened the competitiveness of the proposal. The American Academy of Family Physicians National Research Network brings crucial research expertise and a lot of experience doing this kind of real-world research across diverse family practices throughout the country.”

Sorensen concurred that it was key to involve physicians.

“The fact that this is being done in partnership with another discipline is critical to the growth and development of change,” he said, adding that he felt the University of Minnesota College of Pharmacy didn’t have the full scope of research experience it needed to put forth a proposal alone. “[We knew that] working with North Carolina would create a stronger proposal because there would be a more robust level of experience,” he continued. “AIMM adds its seven years of experience of managing a national learning collaborative, stimulating practice change through quality improvement

processes. It’s a vehicle we can use to share what we’re learning to a broad audience as quickly as possible.”

McClurg said that efforts to optimize medication use need to be included in discussions to transform healthcare delivery and payment reform. “Medication is a critical component that’s overlooked in improving national healthcare,” she noted. “In this study we hope to ensure the safe, effective and affordable use of medication by employing CMM in the context of primary care delivery. For too long pharmacists have spoken a language full of mixed terminologies and there is little acceptance of what exactly it is that pharmacists can do.

Yet, everyone understands that to improve national healthcare we have to optimize medication use.”

McClurg added that this research “is learning what best practices are and how to then replicate and scale those best practices. That alone will advance pharmacy.” The other outcome they hope to gain from this research, she continued, is to accelerate payment reform. “We need to engage payers and policymakers to ensure that we are conducting work that not only advances healthcare delivery, but recognizes medication optimization as a value-added component of payment reform.” P Jane E. Rooney is a freelance writer based in Oakton, Virginia.

The Power of Plants UIC will use $10M in federal grants to study botanicals for human health.

By Sam Hostettler The University of Illinois at Chicago College of Pharmacy has received a five-year, $9 million grant from the National Institutes of Health to continue its research into the safety and efficacy of botanical dietary supplements for women’s health, and another $1.2 million over five years to develop new chemical and biological approaches to the investigation of natural products.

UIC is one of only three Botanical Dietary Research Centers to be funded by the NIH’s Office of Dietary Supplements and National Center for Complementary and Integrative Health, and one of only two funded Centers for Advancing Natural Products Innovation and Technology for the five-year funding cycle that begins this year.

6

Academic Pharmacy NOW  2015 Issue 5

Researchers in the UIC/NIH Center for Botanical Dietary Supplements will undertake three projects to investigate botanicals used by older women for the management of menopausal symptoms such as hot flashes, said center director Dr. Richard van Breemen, professor of medicinal chemistry and pharmacognosy.

“We believe that botanical dietary supplements can be used as safe and effective alternatives to hormone therapy,” van Breemen said.

One project, led by Dr. Guido Pauli, professor of medicinal chemistry and pharmacognosy, will confirm the reliability of supplements being studied and develop methods to craft

campus connection

“designer” supplements from plants for optimal safety and efficacy.

In the third project at UIC, also led by van Breemen, clinical trials of hops, red clover and licorice will look for any interactions between the supplements and prescription drugs.

Another study will evaluate botanicals for biological activity, including estrogenic, chemopreventive, antioxidant and anti- UIC’s botanical center is the only center in the U.S. funded inflammation properties — to see if women who are taking continuously since the NIH began the program in 1999, and botanical dietary supplements for menopausal symptoms its findings have been reported in more than 200 publicacould be seeing additional health benefits. Dr. Judy Bolton, tions. Collaboration among numerous research laboratories professor and head of medicinal chemistry and pharmacogat UIC has been key to the center’s success, van Breemen said. nosy, leads the project along with research assistant profes“Our multi-disciplinary approach comes from our founder, sor Dr. Birgit Dietz. renowned pharmacognosist Norman Farnsworth,” he said.

“We believe that such botanicals as red clover, hops and Farnsworth, who died in 2011 at age 81, “believed that experts licorice will modify the activity of estrogens, which contain in pharmacognosy, chemistry, botany, medicine and phartoxic agents that damage DNA molecules in genes, causing macology working as one will provide the greatest research mutations and tumors in sensitive tissues such as the results,” van Breemen said. “It is one of the reasons for our breast,” Bolton said. The chance for errors occurring in many achievements, and continues to be the cornerstone of DNA can increase dramatically in rapidly dividing cells. the center.” P Other botanicals to be studied include milk thistle, valerian, dang gui, maca, chaste tree berry, kwao keur, wild yam, rose root and five flavor berry. Under the direction of van Breemen and Dr. Elena Barengolts, associate professor of medicine, botanical dietary supplements will be chemically standardized prior to preclinical and clinical studies of safety.

Sam Hostettler is a writer for UIC News.

“We believe that botanical dietary supplements can be used as safe and effective alternatives to hormone therapy,” said Dr. Richard van Breemen, director of the UIC/NIH Center for Botanical Dietary Supplements.

Academic Pharmacy NOW  2015 Issue 5

7

campus connection

A Longer Lifespan for Peptides A new approach developed at University of the Pacific could pave the way for more effective peptide therapies.

Researchers at University of the Pacific have developed a biochemical trick that can significantly extend the lifespan of peptides, smaller cousins of proteins. The finding opens up new possibilities for creating peptides to treat cancer, infertility and other conditions.

The research, led by Dr. Mamoun Alhamadsheh, assistant professor of pharmacy at Pacific, is featured in the November issue of Nature Reviews Drug Discovery, a publication that spotlights high-impact papers from Nature, Cell and other major scientific journals.

8

Academic Pharmacy NOW  2015 Issue 5

“The tremendous therapeutic potential of peptides has not yet been realized, mainly because they can’t survive long in the bloodstream,” Alhamadsheh said. “In our approach, we tagged peptides with a compound that enables it to hitch a ride on a larger protein in blood. This allows the peptides to avoid degradation and survive in the body much longer.”

Peptides have been engineered to treat a range of disorders, including cancer and diabetes. These tiny chains of amino acids can be more potent, selective and safe than larger molecules—but their short lifespan demands high doses and frequent administration, limiting their usefulness.

campus connection

“The extended lifespan provided by our technology will allow less frequent administration of the peptide drug, resulting in lower cost and higher patient compliance and convenience,” Alhamadsheh said.

Added Sravan Penchala, first author of the paper and a doctoral student in Alhamadsheh’s lab: “We believe this is a step toward making patients’ lives better.”

Co-first-author Mark Miller, another doctoral student in Alhamadsheh’s lab, said the approach has broad potential applications. “In addition to its promise in treating disease, the new technique also has potential to enhance imaging and diagnostic agents,” Miller said.

The paper first appeared in the Sept. 7 issue of Nature Chemical Biology. Pacific co-authors are Arindom Pal, Jin Dong, Nikhil Madadi, Jinghang Xie, Patrick Batoon, Trever Cox and Jesse Miles, all doctoral students; Associate Professor Miki Park and Professor William Chan, both of the university’s Thomas J. Long School of Pharmacy and Health Sciences; Hyun Joo, a visiting scholar in the Department of Chemistry; and Associate Professor Jerry Tsai, Professor Vyacheslav Samoshin, and Professor Andreas Franz, all of the Department of Chemistry.

Above: “We believe this is a step toward making patients’ lives better,” said Sravan Penchala, first author and Ph.D. student.

Below: Dr. Alhamadsheh advises co-first author Mark Miller.

“The new technique also has potential to enhance imaging and diagnostic agents,” Miller added.

Photo credits above and opposite page: Randall Gee

The research was supported by grants from the National Institutes of Health and National Science Foundation, as well as an AACP New Investigator Award to lead author Alhamadsheh.

Co-author Park is also a previous recipient of the formerly named AACP New Investigators Program. P

Opposite page: Dr. Mamoun Alhamadsheh is working to lengthen the life of peptides, whose short lifespan demands high doses and frequent administration when treating a range of disorders, from cancer to diabetes.

Academic Pharmacy NOW  2015 Issue 5

9

community impact

A First for Fat Researchers at Washington State University show how fatty acids can fight prostate cancer.

By Eric Sorensen Washington State University researchdiabetes but there has always been bind to a receptor called FFA4, for “free ers have found a mechanism by which an interest in cancer, and we were the fatty acid receptor 4.” Rather than omega-3 fatty acids inhibit the growth first to show this mechanism in any stimulating cancer cells, the receptor and spread of prostate cancer cells. The cancer cell at all. And we’re using pros- acts as a signal to inhibit growth facfindings, which are at odds with a 2013 tate cancer, which is the most controtors, suppressing proliferation of the study asserting that omega-3s increase versial subject in omega 3s.” cancer cells. the risk of prostate cancer, point the “This kind of knowledge could lead us to way to more effective anti-cancer drugs. A 2013 study in the Journal of the National Cancer Institute found that men better treat or prevent cancer because Scientists have long known that omega with higher levels of omega-3 fatty now we know how it works,” Meier said.

3s reduce inflammation and have antiacids in their blood had a greater risk The study also found that a drug mimdiabetic effects, and some recently of developing prostate cancer. It was icking the action of omega 3s can work discovered how this happens. not clear if the fatty acids came from as well or better than fatty acids in food—certain fish, seeds and nuts are suppressing the cancer cells. The study “But we’re the first to show that they high in omega 3s—or supplements like appears in the Journal of Pharmacology work this way in cancer,” said Dr. fish oil. and Experimental Therapeutics.

Kathryn Meier, professor and associate dean for graduate education at the WSU Working with prostate cell cultures, Meier said it is still unclear if the efCollege of Pharmacy. “The attention Meier and two students, Ze Liu and fect can be obtained by taking dietary has mostly been on inflammation and Mandi Hopkins, found the fatty acids supplements like fish oil. Some people

New findings from Washington State University, which are at odds with a 2013 study asserting that omega-3s increase the risk of prostate cancer, point the way to more effective anti-cancer drugs.

10

Academic Pharmacy NOW  2015 Issue 5

community impact

Data from the study suggests an omega-3 drug needs to be in a cancer cell all the time, in order to have an effect. “But now we have a potential drug,” Meier adds. “Once you have a drug you can test very precisely whether it works or not.”

don’t tolerate fish oil very well, she said.

Moreover, the effect of fish oil could fade as it is digested, while data from this study suggest that an omega-3 drug needs to be in a cancer cell all the time to have an effect.

“It’s very difficult in dietary studies to tell how much to take or what form to take,” Meier said. “Should you be eating fish? Should you be taking pills? But now we have a potential drug. Once you have a drug you can test very precisely whether it works or not in a certain disease and you would know exactly how much to give people.” P

“This kind of knowledge could lead us to better treat or prevent cancer because now we know how it works.”

—Dr. Kathryn Meier

Eric Sorensen is a science writer for Washington State University.

Academic Pharmacy NOW  2015 Issue 5

11

community impact

Redefining Diabetes Care— and the Pharmacist’s Role A team from the University of California, San Diego gives patients with type 2 diabetes a healthcare “tune-up.”

By Heather Buschman Healthcare providers are facing increasing pressure to achieve better patient outcomes, faster. With that in mind, Dr. Candis Morello and her team of UC San Diego Skaggs School of Pharmacy and Pharmaceutical Sciences students set up a diabetes intensive medical management “tune-up” clinic for complex type 2 diabetes patients at the Veterans Affairs San Diego Healthcare System. The clinic, unique for its management by a pharmacist, pharmacy students and endocrinologist, provides personalized clinical care and realtime, patient-specific diabetes education in hour-long visits.

“We developed the clinic to empower patients through very patient-specific clinical care, as well as very specific education to help them reach their goals,” said Morello, who serves as professor of clinical pharmacy and associate dean for student affairs. “There was a need at the medical center to help our patients achieve better glycemic control, to help the medical center achieve better target markers, and to help the primary care provider meet their patients’ targets.”

But is the diabetes tune-up clinic any better at achieving patient outcomes than regular visits to a primary care provider?

A new paper Morello and team published in the Annals of Pharmacotherapy says yes.

In the study, the team compared A1C, a measure of blood sugar levels, between two groups of patients—99 who attended the clinic for three one-hour visits over six months, and 56 who saw their primary care physicians at least two times in six months. The clinic group experienced significantly greater improvements at six months: compared to an average A1C reduction of just 0.8 percent in the primary care group, the tune-up clinic patients reduced their A1C by an average of 2.4 percent, and three-quarters reached their target goals.

12

Academic Pharmacy NOW  2015 Issue 5

“This personalized approach to diabetes management is pushing the boundaries of pharmacy and healthcare,” Morello explained. “We’re teaching lifelong skills in just six months—that’s a very short time to achieve chronic longterm goals. And preliminary data shows the benefits are maintained even 12 months after a patient leaves our tuneup clinic.”

Furthermore, the diabetes clinic patients experienced a few other clinically significant improvements—they didn’t gain weight and didn’t experience any low blood sugar incidents.

This collaborative tune-up model was likely so successful in part, Morello said, because many of the patients have several other health issues that also need to be discussed at regular physician visits, leaving little time to talk about diet, exercise and managing blood sugar levels. The diabetes clinic dedicates time specifically to those matters, freeing up primary care providers to address a patient’s other conditions.

This pharmacist-led clinic exemplifies the changing landscape in pharmacy. California recently expanded pharmacists’ scope of practice, allowing them to initiate and monitor a patient’s drug therapy, rather than simply fulfill a doctor’s prescription. “The clinic is positive, interactive, engaging and educating, which really demonstrates the pharmacist in action. Hopefully, with the dissemination of this model, it would be adopted and duplicated in other health systems.” P Heather Buschman, Ph.D., is senior manager of communications and media relations at the University of California, San Diego Health.

community impact

“This personalized approach to diabetes management is pushing the boundaries of pharmacy and healthcare.”

—Dr. Candis Morello

Dr. Candis Morello reveals to a happy patient the progress he’s made after visiting the clinic. Within six months of attendance, the patient had reversed the damage caused by stage 2 chronic kidney disease by gaining control of his blood glucose levels.

Photo credit: University of California, San Diego

Academic Pharmacy NOW  2015 Issue 5

13

community impact

14

Academic Pharmacy NOW  2015 Issue 5

community impact

Moving Pharmacy Forward,

By Looking Back ‘Pharmacy of the future’ redefines the relationship between the patient and pharmacist.

By Athena Ponushis Northeast Ohio Medical University and Ritzman Pharmacy are bridging the chasm between higher education and pharmacy practice, to create a “pharmacy of the future.”

“One of the hardest parts is figuring out how you engage someone,” said Dr. Charles Taylor, dean of the NEOMED College of Pharmacy and president of Pharmacy Innovations, an affiliate of the university.

Set in a healthcare ecosystem on the NEOMED campus, next to a medical fitness facility and primary care physician office, “I, just like anyone else, can read the statistics indicating the pharmacy will use technology to engage the tech savvy how many people don’t take their prescriptions the way they — individuals wearing Fitbits or smartwatches, using social should, or how individuals could benefit from advanced media or apps to track their fitness — and the use of these services like medication management or transitions of care. digital tools will open up time for pharmacists to cultivate The harsh reality is this: look across the country, we’re not relationships and engage with patients who are fond of delivering that service as well as I think we can, but we will vintage-inspired, face-to-face care. be in the future.”

Academic Pharmacy NOW  2015 Issue 5

15

community impact

Technology Beaming Up Pharmacy This visionary pharmacy, expected to open in early 2016, will include a station much like an Apple store “genius bar,” where a patient may use an iPad or smart device to download an app or watch a video about a medication or condition, then pose questions to a pharmacist.

the heart of this innovative practice model rests small-town, vintage care.

If you look back 30 or 40 years, he said, the pharmacist was one of the most respected members of the community.

Everyone knew their pharmacist and they were integral to patients’ care.

There will also be private rooms, where a patient can talk one-on-one with a pharmacist, as well as a larger room, where support groups may gather. Technology will enable pharmacists, students and faculty to transcend the walls of the pharmacy, too.

“I think we lost our way in pharmacy for awhile and became solely focused on the production of the prescription,” Glatcz said. “What we’re trying to do is bring that philosophy back into the present,” making the pharmacist a leader in the community, “and we call that pioneering vintage care.”

“We want to work with health plans and local health systems to improve the medication reconciliation experience and we are doing that through a telepresence component. We’ll be able to connect a pharmacist with other health professionals if they have questions about a medication, and be broadcast into small primary care clinics, talk one-on-one with patients or perhaps with other pharmacists to create a network of practitioners who are delivering more advanced patient care,” Taylor said.

This innovative pharmacy will be using novel technologies to alleviate administrative burdens behind the counter, bringing the pharmacist back in front of the community.

Telepresence technology will allow the pharmacy to help with medication adherence or medication management, whether it’s on campus or in someone’s home.

Such automation will also allow the university to leverage its faculty, connecting an expert with advanced credentials in psychiatric medication, for example, to a mental health patient or provider in a more rural, underserved part of the state.

Sounds ‘Star Wars,’ But Really Vintage Care When people hear “pharmacy of the future,” they think “Star Wars,” said George Glatcz, chief operating officer of Ritzman Pharmacy, which has 25 locations in northeast Ohio. But at

“What a better way than through an academic institution to set up a model and measure outcomes.”

—George Glatcz, COO, Ritzman Pharmacy

16

Experience Over Convenience When Ritzman asked its customers what they wanted from their pharmacy experience, no one could really articulate it.

There was no expectation of care.

“Patients thought, ‘I’ll just pick up my prescription and go, there’s no need to have a conversation with my pharmacist.’”

Glatcz said. “Hearing those sentiments took away what the practice of pharmacy is all about—patient care.”

It’s the patient experience that will make this pharmacy different, Glatcz added, who likens the current pharmacy experience to buying a cup of coffee years ago when you would run into a convenient store, grab a cup and run out. It better be hot and fast.

Glatcz believes the same thing has happened in community pharmacy. Patients think ‘My prescription better be ready so I can run in and run out,’ but he believes this too can be revolutionized, just like the coffee house experience.

community impact

The Next Generation of Pharmacy This state-of-the-art facility will change the patient experience — come in, workout, see your primary care doctor, spend hours on your laptop at a pharmacy — but it will change the student experience, too.

These renderings showcase Northeast Ohio Medical University and Ritzman Pharmacy’s “pharmacy of the future,” designed around digital health technology to engage patients with their pharmacist.

When Taylor held listening sessions with faculty about the future of NEOMED, they consistently voiced a desire for innovation and the creation a model to build the next generation of innovators.

“It became apparent that we needed to be the model,” Taylor said. “And we need to use it as a case example with our students to inspire them. It has to be more than just words, more than curriculum; we needed a comprehensive approach, aligned with real, authentic opportunities.”

Now, NEOMED students will be immersed in a true pharmacy practice from day one. The rigor of it will grow, the complexities of patients and practices will elevate, and they will be able to see what pharmacy practice can be, and what it should be, Taylor said.

Glatcz feels the best part of this collaboration with NEOMED will be measuring outcomes to add to the momentum of pharmacy’s evolution.

“What a better way than through an academic institution to set up a model and measure outcomes,” Glatcz said, which ensures the future of pharmacy circles back to its original mission: building relationships with patients. P Athena Ponushis is a freelance writer based in Ft. Lauderdale, Florida.

Academic Pharmacy NOW  2015 Issue 5

17

@AACPharmacy

AJPE Call for Papers on Interprofessional Education The American Journal of Pharmaceutical Education (AJPE), in conjunction with The Journal of the American Osteopathic Association (JAOA), is seeking original research, reviews, and commentary for a special joint theme issue on interprofessional education.

Manuscripts should demonstrate achievement of one or more of the four Interprofessional Collaborative Practice Competencies (https://ipecollaborative.org/uploads/IPEC-Core-Competencies.pdf): 33 Values/ethics for interprofessional practice 33 Roles and responsibilities for collaborative practice 33 Interprofessional communication practices 33 Interprofessional teamwork and team-based practice

These papers may also involve the education of other healthcare professionals, but pharmacy and osteopathic medicine must be key players in these innovative, collaborative educational programs.

Manuscripts must follow the submission requirements (e.g., abstract, length) of either AJPE (http://www.ajpe.org/page/author-instructions) or JAOA (http://jaoa.org/ss/authors.aspx). All selected papers will undergo the peer review process and are subject to the approval of the editors of both journals. Papers accepted for publication will be published in 1 of these 2 journals, currently planned for late summer or fall 2016.

Interested groups should direct questions and submit their manuscripts for consideration via e-mail with the subject line “JAOA-AJPE interprofessional education” to either AJPE (ajpe@ajpe.org) or JAOA (jaoa@osteopathic.org).

Submissions are due February 1, 2016.

18

Academic Pharmacy NOW  2015 Issue 5

@AACPharmacy

2016 AACP Interim Meeting February 20–23

HF

Tampa Marriott Waterside Hotel & Marina

HF

Tampa, Florida

Innovation and Effective Leadership Interim Meeting is the best opportunity you’ll have all year to address some of the most challenging topics facing you and your institution, such as:

New This Year:

• How do you lead change without resistance? Our keynote speaker addresses the Signature Style™ and how it motivates individuals to make more of the right decisions, more often.

ɖɖ Interim Meeting attendees can earn more than 10 hours of CE credit!

• How do you communicate and recruit in a competitive environment? Learn how effective messaging and outreach strategies stimulate interest in pharmacy and pharmacy education.

Follow us on Twitter @ AACPharmacy and use the Interim Meeting hashtag #AACPInterim.

• How do you stimulate higher human and organizational flourishing? The intersection of leadership and well-being will be explored, bridging science with evidence-based practices.

Register online: www.aacp.org/interimmeeting16

Maximize Your AACP Membership in 2016 Renew your membership and utilize all of the professional development opportunities AACP has to offer: • Collaborate with peers through AACP Sections & SIGs • Stay informed via AJPE, Academic Pharmacy Now and enhanced E-Lert Newsletters • Take advantage of targeted Webinar programming • Experience new learning technology via Mimycx • Apply for start-up funding through the New Investigator Award • Join more than 2,300 of your colleagues attending the Annual Meeting • And much more at www.aacp.org

Renew your membership today: http://www.aacp.org/about/join/Pages/default.aspx Academic Pharmacy NOW  2015 Issue 5

19

2016 AACP Institute Leading Edge:

Transforming Experiential Education for 2025 The Marquette Hilton Hotel, Minneapolis, MN • May 23–25, 2016 The 2016 AACP Institute will focus on experiential education programs within a college or school of pharmacy. Three to five representatives from an institution will form an action plan for breaking down the silos between experiential education and the entire curriculum. In addition, the “home team” members will address the aspects of quality assurance, assessment and interprofessional education relative to experiential education.

May 2016

Who should attend?

• Associate/Assistant Deans of Academic Affairs • Faculty members involved in leading curricular change • Experiential Education Directors and Preceptors

Save the Date